Blog
Treatment-Resistant Depression: A Closer Look at Four Augmentative Treatments
In conclusion, this research provides valuable insights into the comparative benefits and drawbacks of four augmentative treatments for TRD. For Dr. Danish and his team at Philadelphia Integrative Psychiatry
Ketamine and Esketamine for Depression: What is the Ideal Dose?
The study concludes that for IV ketamine, lower doses within the range of 0.2 to 0.5 mg/kg are effective for treatment-resistant depression without additional benefits at higher doses.
Esketamine for Postpartum Depression: A Clinical Trial Insight
In the realm of mental health, innovative treatments are constantly being explored to offer hope and relief to those suffering from various conditions.